NeurosciencebioRxivPreprint
Identifying potential key genes and existing drugs for Multiple sclerosis, Schizophrenia, and Autism- an in silico approach
Sajal Kumar Dey, Sushmita Bhowmick, Souvik Chakraborty
This study identifies 15 key genes and 37 FDA-approved drugs potentially relevant to Multiple sclerosis, Schizophrenia, and Autism using bioinformatics tools and drug-gene interaction analysis.
DOI 10.1101/2021.11.30.470019